Stanley D. Chamberlain

Inhibition of colony-stimulating-factor-1 signaling<i>in vivo</i>with the orally bioavailable cFMS kinase inhibitor GW2580

James G. Conway, Brad McDonald, Janet H. Parham et al. · Proceedings of the National Academy of Sciences · 2005 · 252 citations · Full text

Design, Synthesis, and Antiviral Activity of α-Nucleosides:  <scp>d</scp>- and <scp>l</scp>-Isomers of Lyxofuranosyl- and (5-Deoxylyxofuranosyl)benzimidazoles

Michael T. Migawa, Jean‐Luc Girardet, John Walker et al. · Journal of Medicinal Chemistry · 1998 · 211 citations

Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus

Christopher McGuigan, Karolina Madela, Mohamed Aljarah et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 99 citations

Hepatology, Hepatitis C Virus, Viral Hepatitis +9

GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers

Peter Sabbatini, Susan Korenchuk, Jason L. Rowand et al. · Molecular Cancer Therapeutics · 2009 · 98 citations · Full text

Antitumor Activity, Immunology, Glucose Homeostasis +16

Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors

Kirk L. Stevens, David Jung, Michael J. Alberti et al. · Organic Letters · 2005 · 87 citations

Medicinal Chemistry, Heterocyclic, P38 Kinase Inhibitors +14